Applied BioCode Corporation
TWSE:6598.TW
24.35 (TWD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 413.194 | 831.322 | 646.07 | 847.91 | 302.676 | 349.026 | 247.182 | 55.366 | 134.943 | 202.665 | 40.776 | 140.536 |
Short Term Investments
| 191.622 | 0 | 0 | 0 | 121.326 | 1.543 | 0.89 | 333.634 | 58.139 | 55.7 | 22.47 | 21.785 |
Cash and Short Term Investments
| 604.816 | 831.322 | 646.07 | 847.91 | 424.002 | 350.569 | 248.072 | 389 | 193.082 | 258.365 | 63.246 | 162.321 |
Net Receivables
| 51.044 | 70.81 | 67.805 | 49.472 | 24.102 | 5.676 | 6.243 | 1.724 | 5.461 | 4.47 | 2.263 | 5.63 |
Inventory
| 174.974 | 106.679 | 101.374 | 106.432 | 82.57 | 60.451 | 17.789 | 14.832 | 5.988 | 7.307 | 6.218 | 11.979 |
Other Current Assets
| 6.527 | 5.477 | 11.197 | 17.263 | 9.365 | 6.712 | 3.341 | 2.426 | 3.749 | 4.265 | 0.476 | 0.826 |
Total Current Assets
| 837.361 | 1,014.288 | 826.446 | 1,021.077 | 540.039 | 423.408 | 275.445 | 407.982 | 208.28 | 274.407 | 72.203 | 180.756 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 131.14 | 169.623 | 162.77 | 171.519 | 120.95 | 45.961 | 30.989 | 27.282 | 16.983 | 11.581 | 12.716 | 2.23 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 6.019 | 10.378 | 13.434 | 17.196 | 21.974 | 26.677 | 22.943 | 28.249 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 6.019 | 10.378 | 13.434 | 17.196 | 21.974 | 26.677 | 22.943 | 28.249 | 31.061 | 33.232 | 34.42 | 36.432 |
Long Term Investments
| 6.279 | 0 | 0 | 0 | 0 | 3.07 | -7.452 | 0 | -24.947 | -23.971 | 52.746 | 21.787 |
Tax Assets
| 4.499 | 3.985 | 3.513 | 4.6 | 5.979 | 12.61 | 7.452 | 8.739 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 7.909 | 14.175 | 12.804 | 12.829 | 30.065 | 2.346 | 7.452 | 6.517 | 79.616 | 59.411 | 22.47 | 21.785 |
Total Non-Current Assets
| 155.846 | 198.161 | 192.521 | 206.144 | 178.968 | 90.664 | 61.384 | 70.787 | 102.713 | 80.253 | 122.352 | 82.234 |
Total Assets
| 993.207 | 1,212.449 | 1,018.967 | 1,227.221 | 719.007 | 514.072 | 336.829 | 478.769 | 310.993 | 354.66 | 194.555 | 262.99 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 2.584 | 8.727 | 9.428 | 27.602 | 9.582 | 11.913 | 0.569 | 4.182 | 1.869 | 0.671 | 0.031 | 0.106 |
Short Term Debt
| 16.353 | 15.664 | 14.195 | 12.696 | 71.654 | 1.958 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 4.175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 43.249 | 22.766 | 36.221 | 37.465 | 30.909 | 2.22 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 36.794 | 31.741 | -13.5 | -27.563 | -9.567 | 26.986 | 35.724 | 29.804 | 23.391 | 25.568 | 8.444 | 4.175 |
Total Current Liabilities
| 101.564 | 87.625 | 59.947 | 77.802 | 112.16 | 54.99 | 36.862 | 38.168 | 27.129 | 26.91 | 8.506 | 4.387 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 18.078 | 33.448 | 44.562 | 48.732 | 63.043 | 6.544 | -15.99 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 208.076 | 271.325 | 7.988 | 9.092 | 7.175 | 7.202 | 15.99 | 4.267 | 4.127 | 1.57 | 0.378 | 0 |
Deferred Tax Liabilities Non-Current
| 4.499 | 3.985 | 3.513 | 4.6 | 5.979 | 12.61 | 7.452 | 8.739 | 9.419 | 10.492 | 14.746 | 15.608 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 15.99 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 230.653 | 308.758 | 56.063 | 62.424 | 76.197 | 26.356 | 23.442 | 13.006 | 13.546 | 12.062 | 15.124 | 15.608 |
Total Liabilities
| 332.217 | 396.383 | 116.01 | 140.226 | 188.357 | 81.346 | 60.304 | 51.174 | 40.675 | 38.972 | 23.63 | 19.995 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 68.468 | 47.269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 817.684 | 817.634 | 817.292 | 816.39 | 722.854 | 620.058 | 505.679 | 464.136 | 284.841 | 259.916 | 212.103 | 212.463 |
Retained Earnings
| -193.164 | -349.932 | -165.199 | -1,052.108 | -948.612 | -668.539 | -400.234 | -136.774 | -799.865 | -778.603 | -707.431 | -499.411 |
Accumulated Other Comprehensive Income/Loss
| 33.146 | 27.397 | -68.468 | -47.269 | 8.911 | 20.647 | 9.896 | 43.077 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 3.324 | 320.967 | 250.864 | 1,322.713 | 747.497 | 460.56 | 161.184 | 57.156 | 785.342 | 834.375 | 666.253 | 529.943 |
Total Shareholders Equity
| 660.99 | 816.066 | 902.957 | 1,086.995 | 530.65 | 432.726 | 276.525 | 427.595 | 270.318 | 315.688 | 170.925 | 242.995 |
Total Equity
| 660.99 | 816.066 | 902.957 | 1,086.995 | 530.65 | 432.726 | 276.525 | 427.595 | 270.318 | 315.688 | 170.925 | 242.995 |
Total Liabilities & Shareholders Equity
| 993.207 | 1,212.449 | 1,018.967 | 1,227.221 | 719.007 | 514.072 | 336.829 | 478.769 | 310.993 | 354.66 | 194.555 | 262.99 |